TDM-1 was the name given to the drug during the clinical trial. One thing that’s not any different is the price of another life extending drug, about $9800 a month and will be available in a couple of weeks. Kadcyla is a combination of a current cancer drug, Herceptin and a chemotherapy drug named DM-1. It is to be prescribed when Herceptin is no longer effective on it’s own. DM-1 on it’s own is way too toxic to delivery into the bloodstream alone. A normal course of treatment is about 9 months so you can do the math here to see at the price listed above, it is expensive. Of course they do have a hardship program where some might be able to get the drug for free. BD
FDA Approves New Late Stage Breast Cancer Drug From Roche, Life Extending Kadcyla
2/23/2013 05:48:00 PM
Medically Related, Pharma/FDA News
![EZClaim[4]](http://lh4.ggpht.com/_v3zjJigoAPE/TG1-9etl5ZI/AAAAAAAAgqg/CRMlet5Pi5k/EZClaim44.png?imgmax=800 "EZClaim[4]")
Math–This Could be a Subject for Michael Moore to Explore and Document In a Movie
Screenings Too–Killer Algorithms Part 12–Medical Billing Codes Style
Assessing Consumer Credit Scores–Attack of the Killer Algorithms Chapter 21 With Flawed Data
Duping” Society Combined With A World of Rogue Algorithms & Flawed Data Continues In Markets As Seen With Knight Capital This Week-Attack of the Killer Algorithms Chapter 36
Study Fraud With EHR Technologies, Namely Medical Records/Billing Software Used by Hospitals– HHS And SEC Continue Getting Their Non-Algorithmic Fannies Kicked–Attack of the Killer Algorithms Chapter 46
SilverScript Senior Drug Program Sanctioned by Medicare Until the Payment And Billing Algorithms are Cleaned Up-Killer Algorithms Chapter 53
